A prospective, randomized controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with interstitial lung disease
Not Applicable
- Conditions
- interstitial lung disease (ILD)
- Registration Number
- JPRN-UMIN000004041
- Lead Sponsor
- agasaki University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. severe orthopedic or neurological disorders 2. unstable cardiac disease 3. weak skin 4. malignancy 5. pregnant 6. inability to understand to use EMS equipment 7. inability to complete questionnaires
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method isometric quadriceps force MRC dyspnea scale 6-min walk distance
- Secondary Outcome Measures
Name Time Method ADL score St. George's Respiratory Questionnaire (SGRQ)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie transcutaneous electrical muscle stimulation in interstitial lung disease?
How effective is transcutaneous electrical muscle stimulation compared to pulmonary rehabilitation in ILD patients?
Are there specific biomarkers that predict response to lower extremity electrical muscle stimulation in ILD?
What adverse events are associated with transcutaneous electrical muscle stimulation for ILD treatment?
What combination therapies enhance the effects of electrical muscle stimulation in interstitial lung disease?